News
11h
24/7 Wall St. on MSNLive Vanguard IT ETF (VGT): Markets Blink on Tariff Uncertainty in Mixed ShowingLive Updates Live Coverage Has Ended Markets Await Ford's Earnings 4:08 pm by Gerelyn Terzo The markets succumbed to selling ...
11h
24/7 Wall St. on MSNS&P 500 INDEX (SPX) Live: The Markets Turn Cautious in Data-Filled WeekLive Updates Live Coverage Has Ended Markets Pivot to Ford Earnings 4:03 pm by Gerelyn Terzo The markets failed to turn ...
10h
24/7 Wall St. on MSNHims & Hers (NYSE: HIMS) Earnings Are In (Live Coverage)Hims & Hers Health (NYSE: HIMS) will report its Q1 2025 financial results today, after the market closes with a conference ...
Q4 Results 2025 Live: As April chimes in, so does Q4 results. Around 53 companies are announcing their results for the ...
Investors kickoff the week awaiting more developments on President Trump’s trade deals and the decision on interest rates by ...
22h
VnExpress International on MSNVN-Index surges to 3-week high as new trading system goes liveVietnam's benchmark VN-Index rose 1.12% to 1,240.05 points Monday, its highest in three weeks, as the new KRX trading system ...
Kick off your morning with our special report that exposes the extent of Ireland's corporation tax mirage, and the hundreds ...
TJX Companies, Inc. has shown strong growth in revenue and profitability driven by increased store count and comparable store ...
Focused on enhancing productivity and extending the life of its assets, the Company's goal is to increase its share price and provide investor yield. Rob McEwen, Chairman and Chief Owner, has a ...
The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results